| Company | product name | Generic name | 2010 rev (mUSD) | 2009 rev (mUSD) | Rev Change | 2010 Rank | 2009 Rank | Rank Change | YoY rev growth (%) | Patent Numbers | Expiration of first patent (US) | Expiration of last patent (US) | Patent Expiration (EU) | ATC code | type of drug | drug target | type of drug (function) | PDB | Company |
| Pfizer | Lipitor | Atorvastatin | 10733 | 11434 |   | 1 | 1 | 0 | 0 | 4,681,893 | 2011.01.01 |   |   | C10 | small molecule drug | HMG CoA reductase inhibitor | lipid regulator |   | Pfizer |
| GlaxoSmithKline | Seretide (EU), Advair (US) | Fluticasone/salmeterol | 7900 | 8098 |   | 2 | 4 | 2 | 0 |   | 2011.01.01 |   |   | R03 | small molecule drug (corticosteroid) |   | asthma |   | GlaxoSmithKline |
| Hoffmann-La Roche | Avastin | Bevacizumab | 6800 | 5013 |   | 3 | 11 | 8 | 0 | 6,054,297 | 2018 |   |   | L01 (Antineoplastic) | protein (mAb) |   |   |   | Hoffmann-La Roche |
| Bristol Myers Squibb | Plavix | Clopidogrel | 6700 | 9059 |   | 4 | 2 | -2 | 0 | 4,847,265 | 2011.01.01 |   |   | B01 (antithrombotic) | small molecule drug | GPCR inhibitor (glycoprotein IIb/IIIa pathway inhibitor) |   |   | Bristol Myers Squibb |
| Hoffmann-La Roche | MabThera / Rituxan | Rituximab | 6700 | 4681 |   | 4 | 13 | 9 | 0 |   | 2015 |   |   | L01 (Antineoplastic) | protein (mAb) | CD20 |   |   | Hoffmann-La Roche |
| Abbott Laboratories | Humira | Adalimumab | 6500 | 5032 |   | 6 | 10 | 4 | 0 | 6,090,382 | 2016 |   |   | L04 (Immunosuppressant) | protein (mAb) | TNFalpha |   |   | Abbott Laboratories |
| Novartis | Diovan | Valsartan | 6053 | 3912 |   | 7 | 19 | 12 | 0 | 5,399,578 | 2012.01.01 |   |   | C09 | small molecule drug |   |   |   | Novartis |
| Novartis | Co-Diovan | Hydrochlorothiazide | 6053 | 2617 |   | 7 | 33 | 26 | 1 |   | 2012.01.01 |   |   | C03 (Diuretic) | small molecule drug |   |   |   | Novartis |
| AstraZeneca | Crestor | Rosuvastatin | 5700 | 5383 |   | 9 | 8 | -1 | 0 | RE37314 | 2016 |   |   | C10 | small molecule drug |   |   |   | AstraZeneca |
| Hoffmann-La Roche | Herceptin | Trastuzumab | 5700 | 3890 |   | 9 | 20 | 11 | 0 | 5,399,578 | 2012.01.01 |   |   | C09 | protein (mAb) | CD340 |   |   | Hoffmann-La Roche |
| Eli Lilly | Zyprexa | Olanzapine | 5030 | 5295 |   | 11 | 9 | -2 | 0 | 5,229,382 | 2011.01.01 |   |   | N05 (Psycholeptic) | small molecule drug |   |   |   | Eli Lilly |
| AstraZeneca | Nexium | Esomeprazole | 5000 | 8236 |   | 12 | 3 | -9 | 0 |   | 2015 |   |   | A02 (Antacid) | small molecule drug | H+/K+-ATPase inhibitor (gastric) |   |   | AstraZeneca |
| Merck & Co. | Singulair | Montelukast | 5000 | 4986 |   | 12 | 12 | 0 | 0 | 5,565,473 | 2012.01.01 |   |   | R03 | small molecule drug | leukotriene receptor antagonist |   |   | Merck & Co. |
| Amgen | Neulasta | Pegfilgrastim (PEGylated filgrastim) | 4800 | 3678 |   | 14 | 22 | 8 | 0 |   | 2015 |   | 2015 | L03 (Immunostimulant) | protein (insulin) | growth factor / immunostimulant / cytokine (granulocytes) |   |   | Amgen |
| Amgen | Neupogen | Filgrastim | 4800 | 1322 |   | 14 | 83 | 69 | 2 |   | 2013 |   |   |   |   | granulocytes | growth factor |   | Amgen |
| Sanofi-Aventis | Lantus | Insulin Glargine | 4700 | 3968 |   | 16 | 18 | 2 | 0 | 6,100,376 | 2009 |   |   | A10 (Diabetes) | protein (insulin) |   |   |   | Sanofi-Aventis |
| Johnson & Johnson | Remicade | Infliximab | 4600 | 5453 |   | 17 | 7 | -10 | 0 |   | 2018 |   |   | L04 (Immunosuppressant) | protein (mAb) | TNFalpha |   |   | Johnson & Johnson |
| Novartis | Gleevec (US) / Glivec (EU) | Imatinib | 4265 | 3419 |   | 18 | 24 | 6 | 0 |   |   |   |   | L01 (Antineoplastic) | small molecule drug |   |   |   | Novartis |
| Takeda Pharmaceuticals | Actos | Pioglitazone | 4200 | 4116 |   | 19 | 16 | -3 | 0 | 4,687,777 | 2011.01.01 |   |   | A10 (Diabetes) | small molecule drug (racemate) |   |   |   | Takeda Pharmaceuticals |
| AstraZeneca | Seroquel | Quetiapine | 4100 | 5974 |   | 20 | 5 | -15 | 0 | 4,879,288 | 2012.01.01 |   |   | N05 (Psycholeptic) | small molecule drug (thiazepine) | GPCR (serotonin receptor) inhibitor |   |   | AstraZeneca |
| Boehringer Ingelheim | Spiriva | Tiotropium | 3800 | 3499 |   | 21 | 23 | 2 | 0 |   | 2021 |   |   | R03 | small molecule drug |   |   |   | Boehringer Ingelheim |
| Sanofi-Aventis | Lovenox | Enoxaparin | 3700 | 4552 |   | 22 | 15 | -7 | 0 | 5,389,618 | 2012.01.01 |   |   | B01 (antithrombotic) | small molecule drug (heparin) |   |   |   | Sanofi-Aventis |
| Novo Nordisk | Novolog | Insulin | 3585 | 2954 |   | 23 | 28 | 5 | 0 | 5,866,538 | 2017 |   |   | A10 (Diabetes) | protein (endocrine) |   |   |   | Novo Nordisk |
| Eisai | Aricept | Donepezil | 3500 | 4013 |   | 24 | 17 | -7 | 0 |   | 2010 |   |   | N06 (Psychoanaleptic) | small molecule drug |   |   |   | Eisai |
| Eli Lilly | Cymbalta | Duloxetine | 3460 | 3317 |   | 25 | 26 | 1 | 0 |   | 2013 |   |   | N06 (Psychoanaleptic) | small molecule drug | blocks Serotonin reuptake |   |   | Eli Lilly |
| Amgen | Enbrel | Etanercept | 3274 | 5863 |   | 26 | 6 | -20 | 0 |   | 2012.10.23 | 2023 |   | L04 (Immunosuppressant) | protein (mAb) | TNF |   |   | Amgen |
| Pfizer | Lyrica | Pregabalin | 3100 | 2840 |   | 27 | 29 | 2 | 0 | 5,563,175 | 2013 |   |   | N03 (Antiepileptic) | small molecule drug |   |   |   | Pfizer |
| Gilead Sciences | Atripla | Tenofovir & Emtricitabine & Efavirenz | 2926 | 2414 |   | 28 | 37 | 9 | 0 |   | 2021 |   |   | J05 (Antiviral) | small molecule drug (combination) | HIV reverse transcriptase inhibition |   |   | Gilead Sciences |
| Teva Pharmaceuticals | Copaxone | Glatiramer acetate | 2900 | 2432 |   | 29 | 36 | 7 | 0 | 5,981,589 | 2014 |   |   | L03 (Immunostimulant) | small molecule drug |   |   |   | Teva Pharmaceuticals |
| Sanofi-Aventis | Taxotere | Docetaxel | 2800 | 2689 |   | 30 | 31 | 1 | 0 | 4,814,470 | 2010 |   |   | L01 (Antineoplastic) | small molecule drug |   |   |   | Sanofi-Aventis |
| Gilead Sciences | Truvada | Tenofovir & Emtricitabine | 2650 | 2476 |   | 31 | 35 | 4 | 0 | 5,922,695 | 2021 | 2018 |   | J05 (Antiviral) | small molecule drug (combination) | HIV reverse transcriptase inhibitor (nucleoside analogs) |   |   | Gilead Sciences |
| Daiichi Sankyo | Benicar | Olmesartan | 2600 | 1533 |   | 32 | 65 | 33 | 0 |   | 2016 |   |   |   |   |   |   |   | Daiichi Sankyo |
| Amgen | Aranesp | Epoetin alfa | 2500 | 2752 |   | 33 | 30 | -3 | 0 |   | 2014 |   |   | B03 (Antianemic) | protein (erythropoietin) |   |   |   | Amgen |
| Merck & Co. | Januvia | Sitagliptin | 2400 | 1893 |   | 34 | 51 | 17 | 0 |   | 2017 |   |   |   |   |   |   |   | Merck & Co. |
| Forest Laboratories | Lexapro (US), Cipralex (EU) | Escitalopram | 2300 | 2655 |   | 35 | 32 | -3 | 0 | 6,916,941 | 2012.03.01 |   |   | N06 (Psychoanaleptic) | small molecule drug (enantiomer) |   |   |   | Forest Laboratories |
| Eli Lilly | Alimta |   | 2210 | 1495 |   | 36 | 70 | 34 | 0 |   | 2016 | 2022 |   |   |   |   |   |   | Eli Lilly |
| Merck KGaA | Rebif |   | 2200 | 1837 |   | 37 | 54 | 17 | 0 |   |   |   |   |   | protein (interferon) |   | MS |   | Merck KGaA |
| Novo Nordisk | Novorapid | Insulin | 2100 | 2100 |   | 38 | 46 | 8 | 0 |   |   |   |   | A10 (Diabetes) | protein (insulin) |   |   |   | Novo Nordisk |
| Eli Lilly | Humalog | insulin | 2050 | 1538 |   | 39 | 63 | 24 | 0 |   | 2013 |   |   |   | protein (hormone) |   | endocrine / hormone |   | Eli Lilly |
| Pfizer | Viagra | Sildenafil | 1928 | 1892 |   | 40 | 52 | 12 | 0 | 5,250,534 | 2012.01.01 |   |   | G04BE (erectile dysfunction) | small molecule drug |   |   |   | Pfizer |
| Astellas Pharma | Prograf | Tacrolimus | 1900 | 2018 |   | 41 | 48 | 7 | 0 |   |   |   |   |   |   |   |   |   | Astellas Pharma |
| Pfizer | Xalatan/Xalacom |   | 1749 | 1737 |   | 42 | 57 | 15 | 0 |   | 2011.01.01 |   |   |   |   |   |   |   | Pfizer |
| Pfizer | Effexor | Venlafaxine | 1718 | 3358 |   | 43 | 25 | -18 | 0 | 6,274,171 | 2008 |   |   | N06 (Psychoanaleptic) | small molecule drug (racemate) |   |   |   | Pfizer |
| Eli Lilly | Cialis |   | 1700 | 1599 |   | 44 | 60 | 16 | 0 |   | 2017 |   |   |   |   |   |   |   | Eli Lilly |
| Baxter International | Advate |   | 1700 |   |   | 44 |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Abbott Laboratories | Trilipix / TriCor | Fenofibrate | 1600 | 1594 |   | 46 | 61 | 15 | 0 |   |   |   |   |   |   |   |   |   | Abbott Laboratories |
| Bayer | Betaferon |   | 1600 | 1515 |   | 46 | 67 | 21 | 0 |   |   |   |   |   |   |   |   |   | Bayer |
| Hoffmann-La Roche | Lucentis | Ranibizumab | 1533 | 2163 |   | 48 | 44 | -4 | 0 |   |   |   |   | S01 (Ophthalmological) | protein (mAb) | VEGF receptor |   |   | Hoffmann-La Roche |
| Novartis | Zometa | Zoledronic acid | 1511 | 1811 |   | 49 | 55 | 6 | 0 | 4,939,130 | 2012.01.01 |   |   | M05 |   |   |   |   | Novartis |
| Johnson & Johnson | Risperdal | Risperidone | 1500 | 2297 |   | 50 | 43 | -7 | 0 |   |   |   |   | N05 (Psycholeptic) | small molecule drug |   |   |   | Johnson & Johnson |
| Lundbeck | Cipralex (EU), Lexapro (US) | Escitalopram | 1500 | 987 |   | 50 | 109 | 59 | 0 | RE34712 | 2011.03.01 |   |   | N06 (Psychoanaleptic) | small molecule drug |   |   |   | Lundbeck |
| Abbott Laboratories | Kaletra |   | 1300 | 1053 |   | 52 | 103 | 51 | 0 |   |   |   |   |   |   |   |   |   | Abbott Laboratories |
| GlaxoSmithKline | Flixotide |   | 1200 | 1330 |   | 53 | 81 | 28 | 0 |   |   |   |   |   |   |   |   |   | GlaxoSmithKline |
| Pfizer | Zyvox |   | 1176 | 1141 |   | 54 | 96 | 42 | 0 |   | 2015 |   |   |   |   |   |   |   | Pfizer |
| Eli Lilly | Gemzar |   | 1150 | 1292 |   | 55 | 86 | 31 | 0 |   | 2010 | 2013 |   |   |   |   |   |   | Eli Lilly |
| Eli Lilly | Evista |   | 1020 | 1063 |   | 56 | 100 | 44 | 0 |   |   |   |   |   |   |   |   |   | Eli Lilly |
| Pfizer | Detrusitol/Detrol | Tolterodine | 1013 | 1154 |   | 57 | 95 | 38 | 0 | 5,382,600 | 2012.01.01 |   |   | G04 (Urological) | small molecule drug |   |   |   | Pfizer |
| Otsuka Pharmaceutical | Abilify | Aripiprazole |   | 4657 |   |   | 14 |   |   | 5,006,528 | 2014 |   |   | N05 (Psycholeptic) | small molecule drug |   |   |   | Otsuka Pharmaceutical |
| Takeda Pharmaceuticals | Takepron/Prevacid | Lansoprazole |   | 3778 |   |   | 21 |   |   |   | 2009 |   |   | A02 (Antacid) | small molecule drug | H+/K+-ATPase inhibitor (gastric) |   |   | Takeda Pharmaceuticals |
| Amgen | Epogen | Epoetin alfa |   | 3099 |   |   | 27 |   |   |   | 2013 |   |   | B03 (Antianemic) | protein (erythropoietin) |   |   |   | Amgen |
| GlaxoSmithKline | Valtrex | Valaciclovir |   | 2510 |   |   | 34 |   |   | 4,957,924 | 2009 |   |   | J05 (Antiviral) | small molecule drug | DNA polymerase |   |   | GlaxoSmithKline |
| Merck & Co. | Zetia | Ezetimibe |   | 2397 |   |   | 38 |   |   |   |   |   |   | C10 | small molecule drug | cholesterol absorption inhibition (semi unknown function) |   |   | Merck & Co. |
| Pfizer | Celebrex | Celecoxib |   | 2383 |   |   | 39 |   |   | 5,466,823 | 2014 |   |   | L01 (Antineoplastic) | small molecule drug |   |   |   | Pfizer |
| AstraZeneca | Symbicort | Budesonide & Formoterol Fumarate |   | 2353 |   |   | 40 |   |   |   |   |   |   | R03 | small molecule drug (combination) |   |   |   | AstraZeneca |
| Eisai | Pariet | Rabeprazole |   | 2349 |   |   | 41 |   |   |   |   |   |   | A02 (Antacid) | small molecule drug |   |   |   | Eisai |
| Merck & Co. | Vytorin | Ezetimibe & simvastatin |   | 2315 |   |   | 42 |   |   |   |   |   |   | C10 | small molecule drug (combination) | HMG CoA reductase inhibitor |   |   | Merck & Co. |
| Merck & Co. | Cozaar | Losartan |   | 2135 |   |   | 45 |   |   | 5,210,079 | 2010 |   |   | C09 | small molecule drug |   |   |   | Merck & Co. |
| Biogen Idec | Avonex | Interferon beta-1a |   | 2100 |   |   | 46 |   |   |   |   |   |   | L03 (Immunostimulant) | protein (interferon) |   | immunosuppresant (MS) |   | Biogen Idec |
| Pfizer | Norvasc | Amlodipine |   | 1973 |   |   | 49 |   |   |   |   |   |   |   | small molecule drug |   |   |   | Pfizer |
| AstraZeneca | Arimidex | Anastrozole |   | 1922 |   |   | 50 |   |   |   |   |   |   |   |   |   |   |   | AstraZeneca |
| Johnson & Johnson | One Touch Ultra |   |   | 1840 |   |   | 53 |   |   |   |   |   |   |   |   |   |   |   | Johnson & Johnson |
| Johnson & Johnson | Levaquin | Levofloxacin |   | 1743 |   |   | 56 |   |   |   | 2010 |   |   |   |   |   |   |   | Johnson & Johnson |
| Takeda Pharmaceuticals | Blopress | Candesartan |   | 1705 |   |   | 58 |   |   |   |   |   |   |   |   |   |   |   | Takeda Pharmaceuticals |
| Hoffmann-La Roche | Tamiflu |   |   | 1606 |   |   | 59 |   |   |   | 2016 | 2016 |   |   |   |   |   |   | Hoffmann-La Roche |
| Merck & Co. | Hyzaar |   |   | 1592 |   |   | 62 |   |   |   |   |   |   |   |   |   |   |   | Merck & Co. |
| Sanofi-Aventis | Eloxatine |   |   | 1538 |   |   | 63 |   |   |   |   |   |   |   |   |   |   |   | Sanofi-Aventis |
| Merck & Co. | Nasonex |   |   | 1517 |   |   | 66 |   |   |   |   |   |   |   |   |   |   |   | Merck & Co. |
| Hoffmann-La Roche | Cellcept |   |   | 1505 |   |   | 68 |   |   |   |   |   |   |   |   |   |   |   | Hoffmann-La Roche |
| AstraZeneca | Pulmicort |   |   | 1505 |   |   | 68 |   |   |   |   |   |   |   |   |   |   |   | AstraZeneca |
| Sanofi-Aventis | Stilnox |   |   | 1483 |   |   | 71 |   |   |   |   |   |   |   |   |   |   |   | Sanofi-Aventis |
| Hoffmann-La Roche | Neorecormon |   |   | 1482 |   |   | 72 |   |   |   |   |   |   |   |   |   |   |   | Hoffmann-La Roche |
| Procter & Gamble | Actonel | Risedronate |   | 1472 |   |   | 73 |   |   |   |   |   |   |   |   |   |   |   | Procter & Gamble |
| Johnson & Johnson | Concerta | Epoetin alfa |   | 1463 |   |   | 74 |   |   |   |   |   |   | B03 (Antianemic) |   | erythropoietin | growth factor |   | Johnson & Johnson |
| Boehringer Ingelheim | Micardis |   |   | 1422 |   |   | 75 |   |   |   |   |   |   |   |   |   |   |   | Boehringer Ingelheim |
| UCB | Keppra |   |   | 1406 |   |   | 76 |   |   | 4,943,639 | 2008 |   |   |   | small molecule drug | unknown function | anticonvulsant/antiepileptic |   | UCB |
| Eli Lilly | Erbitux | Cetuximab |   | 1398 |   |   | 77 |   |   |   |   |   |   |   | protein (mAb) | EGFR inhibitor | anticancer (colorectal) |   | Eli Lilly |
| Johnson & Johnson | Topamax |   |   | 1375 |   |   | 78 |   |   |   |   |   |   |   |   |   |   |   | Johnson & Johnson |
| Bristol Myers Squibb | Reyataz | Atazanavir |   | 1338 |   |   | 79 |   |   |   |   |   |   |   |   |   |   |   | Bristol Myers Squibb |
| AstraZeneca | Synagis | Palivizumab |   | 1337 |   |   | 80 |   |   |   |   |   |   |   | protein (mAb) | respiratory syncytial virus |   |   | AstraZeneca |
| Nycomed | Pantozol |   |   | 1324 |   |   | 82 |   |   |   |   |   |   |   | small molecule drug | H+/K+-ATPase inhibitor (gastric) |   |   | Nycomed |
| Novartis | Voltaren |   |   | 1319 |   |   | 84 |   |   |   |   |   |   |   |   |   |   |   | Novartis |
| Merck & Co. | Varivax |   |   | 1300 |   |   | 85 |   |   |   |   |   |   |   |   |   |   |   | Merck & Co. |
| Novo Nordisk | Novomix |   |   | 1257 |   |   | 87 |   |   |   |   |   |   |   |   |   |   |   | Novo Nordisk |
| Novartis | Femara |   |   | 1238 |   |   | 88 |   |   |   |   |   |   |   |   |   |   |   | Novartis |
| Johnson & Johnson | Velcade |   |   | 1237 |   |   | 89 |   |   |   |   |   |   |   |   |   |   |   | Johnson & Johnson |
| Boehringer Ingelheim | Sifrol |   |   | 1232 |   |   | 90 |   |   |   |   |   |   |   |   |   |   |   | Boehringer Ingelheim |
| Pfizer | Prevnar |   |   | 1207 |   |   | 91 |   |   |   |   |   |   |   |   |   |   |   | Pfizer |
| Hoffmann-La Roche | Pegasys |   |   | 1189 |   |   | 92 |   |   |   |   |   |   |   |   |   |   |   | Hoffmann-La Roche |
| Pfizer | Tazocin |   |   | 1186 |   |   | 93 |   |   |   |   |   |   |   |   |   |   |   | Pfizer |
| Hoffmann-La Roche | Bonviva |   |   | 1161 |   |   | 94 |   |   |   |   |   |   |   |   |   |   |   | Hoffmann-La Roche |
| Forest Laboratories | Namenda |   |   | 1140 |   |   | 97 |   |   |   |   |   |   |   |   |   |   |   | Forest Laboratories |
| Hoffmann-La Roche | Tarceva |   |   | 1081 |   |   | 98 |   |   |   |   |   |   |   |   |   |   |   | Hoffmann-La Roche |
| Hoffmann-La Roche | Xeloda |   |   | 1079 |   |   | 99 |   |   |   |   |   |   |   |   |   |   |   | Hoffmann-La Roche |
| Shire plc | Adderall |   |   | 1062 |   |   | 101 |   |   |   |   |   |   |   |   |   |   |   | Shire plc |
| Endo | Lidoderm |   |   | 1062 |   |   | 101 |   |   |   |   |   |   |   |   |   |   |   | Endo |
| Novartis | Sandostatin |   |   | 1051 |   |   | 104 |   |   |   |   |   |   |   |   |   |   |   | Novartis |
| Cephalon | Provigil |   |   | 1021 |   |   | 105 |   |   |   | 2015 |   |   |   | small molecule drug |   |   |   | Cephalon |
| Novo Nordisk | Levemir |   |   | 1021 |   |   | 105 |   |   |   |   |   |   |   |   |   |   |   | Novo Nordisk |
| Pfizer | Zeldox/Geodon |   |   | 1002 |   |   | 107 |   |   |   |   |   |   |   |   |   |   |   | Pfizer |
| GlaxoSmithKline | Augmentin |   |   | 992 |   |   | 108 |   |   |   |   |   |   |   |   |   |   |   | GlaxoSmithKline |
| CSL | Gardasil |   |   | 972 |   |   | 110 |   |   |   |   |   |   |   |   |   |   |   | CSL |
| Abbott Laboratories | Niaspan |   |   | 964 |   |   | 111 |   |   |   |   |   |   |   |   |   |   |   | Abbott Laboratories |
| Pfizer | Sutent |   |   | 964 |   |   | 111 |   |   |   |   |   |   |   |   |   |   |   | Pfizer |
| AstraZeneca | Zoladex |   |   | 962 |   |   | 113 |   |   |   |   |   |   |   |   |   |   |   | AstraZeneca |
| Merck & Co. | Temodal M-Co |   |   | 958 |   |   | 114 |   |   |   |   |   |   |   |   |   |   |   | Merck & Co. |
| Takeda Pharmaceuticals | Enantone |   |   | 957 |   |   | 115 |   |   |   |   |   |   |   |   |   |   |   | Takeda Pharmaceuticals |
| Johnson & Johnson | Duragesic | Fentanyl |   | 951 |   |   | 116 |   |   |   |   |   |   |   |   |   | analgesic |   | Johnson & Johnson |
| GlaxoSmithKline | Lamictal |   |   | 950 |   |   | 117 |   |   |   |   |   |   |   |   |   |   |   | GlaxoSmithKline |
| Novo Nordisk | Novoseven | Factor VII |   | 938 |   |   | 118 |   |   | 4,382,083, 4,456,591, 4,479,938, 5,180,583 | 2010 |   |   |   |   |   | haemostasis |   | Novo Nordisk |
| Boehringer Ingelheim | Combivent |   |   | 938 |   |   | 118 |   |   |   |   |   |   |   |   |   |   |   | Boehringer Ingelheim |
| Teva Pharmaceuticals | Salamol |   |   | 936 |   |   | 120 |   |   |   |   |   |   |   |   |   |   |   | Teva Pharmaceuticals |
| Baxter International | Recombinate | octocog alfa |   | 935 |   |   | 121 |   |   |   |   |   |   |   |   |   | blood coagulation |   | Baxter International |
| Novartis | Exelon |   |   | 933 |   |   | 122 |   |   |   |   |   |   |   |   |   |   |   | Novartis |
| AstraZeneca | Atacand |   |   | 921 |   |   | 123 |   |   |   |   |   |   |   |   |   |   |   | AstraZeneca |
| Astellas Pharma | Vesicare |   |   | 904 |   |   | 124 |   |   |   |   |   |   |   |   |   |   |   | Astellas Pharma |
| AstraZeneca | Losec |   |   | 895 |   |   | 125 |   |   |   |   |   |   |   |   |   |   |   | AstraZeneca |
| GE Healthcare | Omnipaque | Iohexol |   | 889 |   |   | 126 |   |   |   |   |   |   |   |   |   |   |   | GE Healthcare |
| Bayer | Yaz | Drospirenone & Ethinylestradiol |   | 885 |   |   | 127 |   |   |   |   |   |   |   | small molecule drugs (progestogen+estrogen) |   |   |   | Bayer |
| Procter & Gamble | Asacol | Mesalazine |   | 811 |   |   | 128 |   |   |   |   |   |   |   |   |   |   |   | Procter & Gamble |
| Bayer | Yasmin | Drospirenone & Ethinylestradiol |   | 766 |   |   | 129 |   |   |   |   |   |   |   | small molecule drugs (progestogen+estrogen) | granulocytes | immunostimulant |   | Bayer |
| Eli Lilly | Byetta | Exenatide |   | 758 |   |   | 130 |   |   |   | 2017 |   |   |   | protein (endocrine) | GLP-1 analog |   |   | Eli Lilly |
| AstraZeneca | Betaloc | Metroprolol |   | 750 |   |   | 131 |   |   |   |   |   |   |   |   |   |   |   | AstraZeneca |
| Biogen Idec | Tysabri | Natalizumab |   | 714 |   |   | 132 |   |   |   |   |   |   |   | protein |   |   |   | Biogen Idec |
| Celgene | Revlimid |   |   | 703 |   |   | 133 |   |   | 5,635,517 | 2019 |   |   |   | small molecule drug |   |   |   | Celgene |
| Novo Nordisk | Norditropin | GH1 |   | 675 |   |   | 134 |   |   |   |   |   |   |   | protein (hormone) |   | hormone |   | Novo Nordisk |
| Sanofi-Aventis | Telfast | Fexofenadine |   | 671 |   |   | 135 |   |   |   | 2014 |   |   |   |   |   |   |   | Sanofi-Aventis |
| Hoffmann-La Roche | Xolair | Omalizumab |   | 632 |   |   | 136 |   |   |   |   |   |   |   | protein (mAb) | IgE |   |   | Hoffmann-La Roche |
| Actelion | Tracleer |   |   | 614 |   |   | 137 |   |   | 5,292,740 | 2015 |   |   |   | small molecule drug | endothelin receptor antagonist | pulmonary artery hypertension |   | Actelion |
| Eli Lilly | Prozac | Fluoxetine |   |   |   |   |   |   |   |   | 2001 |   |   |   | small molecule drug |   | antidepressant |   | Eli Lilly |
| Allergan | Botox | Botulinum toxin |   |   |   |   |   |   |   |   |   |   |   | M03 | protein |   |   |   | Allergan |
| Novo Nordisk | Novolin | insulin |   |   |   |   |   |   |   |   |   |   |   | A10 (Diabetes) | protein (endocrine) |   | diabetes |   | Novo Nordisk |